Royalty Pharma plc (RPRX)
USD 31.01
(-2.45%)
USD 31.01
(-2.45%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 6.29 Billion USD | -13.59% |
| 2022 | 7.28 Billion USD | 0.29% |
| 2021 | 7.26 Billion USD | 18.67% |
| 2020 | 6.12 Billion USD | -2.92% |
| 2019 | 6.3 Billion USD | -7.47% |
| 2018 | 6.81 Billion USD | -1.25% |
| 2017 | 6.9 Billion USD | 14.65% |
| 2016 | 6.02 Billion USD | -1.58% |
| 2015 | 6.11 Billion USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 7.9 Billion USD | 26.13% |
| 2024 Q1 | 6.26 Billion USD | -0.48% |
| 2023 Q4 | 6.29 Billion USD | 0.43% |
| 2023 Q2 | 7.3 Billion USD | 0.77% |
| 2023 Q3 | 6.27 Billion USD | -14.2% |
| 2023 Q1 | 7.25 Billion USD | -0.49% |
| 2023 FY | 6.29 Billion USD | -13.59% |
| 2022 Q2 | 7.33 Billion USD | 1.32% |
| 2022 FY | 7.28 Billion USD | 0.29% |
| 2022 Q4 | 7.28 Billion USD | 0.44% |
| 2022 Q1 | 7.23 Billion USD | -0.42% |
| 2022 Q3 | 7.25 Billion USD | -1.04% |
| 2021 Q2 | 6.1 Billion USD | 0.53% |
| 2021 FY | 7.26 Billion USD | 18.67% |
| 2021 Q4 | 7.26 Billion USD | -1.07% |
| 2021 Q3 | 7.34 Billion USD | 20.23% |
| 2021 Q1 | 6.07 Billion USD | -0.77% |
| 2020 Q1 | 6.2 Billion USD | -1.58% |
| 2020 FY | 6.12 Billion USD | -2.92% |
| 2020 Q4 | 6.12 Billion USD | -1.1% |
| 2020 Q3 | 6.19 Billion USD | -1.57% |
| 2020 Q2 | 6.29 Billion USD | 1.32% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q4 | 6.3 Billion USD | 0.0% |
| 2019 FY | 6.3 Billion USD | -7.47% |
| 2018 FY | 6.81 Billion USD | -1.25% |
| 2017 FY | 6.9 Billion USD | 14.65% |
| 2016 FY | 6.02 Billion USD | -1.58% |
| 2015 FY | 6.11 Billion USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -1775.525% |
| Alkermes plc | 933.53 Million USD | -574.592% |
| Agenus Inc. | 462.29 Million USD | -1262.239% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | -55.475% |
| Aptorum Group Limited | 5.25 Million USD | -119699.807% |
| Ardelyx, Inc. | 130.76 Million USD | -4716.012% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -1216.408% |
| Bicycle Therapeutics plc | 224.41 Million USD | -2706.25% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -4736.466% |
| ChromaDex Corporation | 26.5 Million USD | -23657.213% |
| Chimerix, Inc. | 19.74 Million USD | -31794.464% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -17802.44% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -8578.272% |
| CRISPR Therapeutics AG | 346.76 Million USD | -1716.074% |
| Precision BioSciences, Inc. | 140.92 Million USD | -4368.892% |
| Dyadic International, Inc. | 2.34 Million USD | -268951.73% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -38623.249% |
| Fortress Biotech, Inc. | 165.93 Million USD | -3695.107% |
| Lantern Pharma Inc. | 2.73 Million USD | -229764.707% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -8710.243% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -178365.65% |
| Incyte Corporation | 1.59 Billion USD | -295.508% |
| IO Biotech, Inc. | 17.55 Million USD | -35771.28% |
| Jaguar Health, Inc. | 45.86 Million USD | -13630.349% |
| Novavax, Inc. | 2.57 Billion USD | -144.825% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -17365.09% |
| Opthea Limited | 264.6 Million USD | -2280.019% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -4718.076% |
| ContextLogic Inc. | 206 Million USD | -2957.069% |
| MiMedx Group, Inc. | 96.33 Million USD | -6437.488% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -13013.91% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -178357.457% |
| NextCure, Inc. | 14.99 Million USD | -41892.145% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -155703.117% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -94217.238% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -13373.891% |
| Vaxcyte, Inc. | 167.44 Million USD | -3660.884% |
| PDS Biotechnology Corporation | 33.25 Million USD | -18834.835% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -2577.375% |
| Pharming Group N.V. | 244.07 Million USD | -2480.196% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -52723.033% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -4828.017% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -95212.488% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -95212.488% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -7539.613% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -94699.97% |
| Acelyrin, Inc. | 86.35 Million USD | -7192.812% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -484610.843% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -43696.94% |
| Summit Therapeutics Inc. | 125.25 Million USD | -4927.713% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -66336.987% |
| Senti Biosciences, Inc. | 52.57 Million USD | -11879.156% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -9056.494% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -4056.477% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -321861.247% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -471428.283% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -2676.311% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -67131.365% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -2668.829% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -1173.498% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -57601.686% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -22791.069% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -51925.763% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -1194.194% |
| Immix Biopharma, Inc. | 3.72 Million USD | -169108.199% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -16554.93% |
| MEI Pharma, Inc. | 8.35 Million USD | -75274.77% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -21604.505% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -1711.831% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -4217.272% |
| Fortress Biotech, Inc. | 165.93 Million USD | -3695.107% |
| Precigen, Inc. | 41.64 Million USD | -15022.375% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -12512.782% |
| AlloVir, Inc. | 45.01 Million USD | -13889.919% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -4731.753% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -4470.074% |
| ImmuCell Corporation | 18.81 Million USD | -33370.92% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -22211.21% |
| Onconetix, Inc. | 23.18 Million USD | -27067.044% |
| PureTech Health plc | 125.58 Million USD | -4914.661% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -70263.821% |
| Elevation Oncology, Inc. | 34.28 Million USD | -18269.879% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -257468.998% |
| Seer, Inc. | 39.36 Million USD | -15897.871% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -10084.627% |
| Innoviva, Inc. | 568.55 Million USD | -1007.649% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -23028.992% |
| ESSA Pharma Inc. | 3.49 Million USD | -180084.094% |
| GlycoMimetics, Inc. | 6.9 Million USD | -91141.589% |
| GT Biopharma, Inc. | 6.63 Million USD | -94842.892% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -2281.921% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -2212.84% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -7394.778% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -64331.778% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -23079.219% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -195126.446% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -8437.099% |
| Aptose Biosciences Inc. | 15.8 Million USD | -39736.05% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -56944.757% |
| Soligenix, Inc. | 7.27 Million USD | -86465.568% |
| Century Therapeutics, Inc. | 175.94 Million USD | -3479.36% |
| Kura Oncology, Inc. | 51.66 Million USD | -12089.931% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -5092.495% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -152272.659% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -95117.721% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -2393.116% |
| Autolus Therapeutics plc | 263.9 Million USD | -2286.281% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -59979.775% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -6986.981% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -13327.924% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -1684.74% |
| GRI Bio, Inc. | 2.69 Million USD | -233402.484% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -777775.331% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -20155.257% |
| IGM Biosciences, Inc. | 220.17 Million USD | -2760.227% |
| INmune Bio, Inc. | 18.86 Million USD | -33287.562% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -2355.391% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -23537.889% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -231563.776% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -191883.272% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -10673.35% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -6449.113% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -2278.817% |
| Coherus BioSciences, Inc. | 823.02 Million USD | -665.169% |
| Verastem, Inc. | 71.18 Million USD | -8746.754% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -12706.17% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -16224.231% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -12770.028% |
| Histogen Inc. | 5.69 Million USD | -110441.724% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -143496.197% |
| Surrozen, Inc. | 8.14 Million USD | -77218.134% |
| Organovo Holdings, Inc. | 2.74 Million USD | -229068.923% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -2006400.392% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -11099.669% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -38039.305% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -12223.273% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -761509.917% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -4869.471% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -58137.477% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -4073.639% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -241431.596% |
| Apollomics, Inc. | 14.15 Million USD | -44396.305% |
| Amarin Corporation plc | 279.58 Million USD | -2152.452% |
| Mesoblast Limited | 188.79 Million USD | -3235.608% |
| Turnstone Biologics Corp. | 14.14 Million USD | -44412.03% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -3383.396% |
| Synaptogenix, Inc. | 5.52 Million USD | -113790.9% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -94628.67% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -3602.096% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -73493.782% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -358246.824% |
| Exelixis, Inc. | 678.44 Million USD | -828.235% |
| Better Therapeutics, Inc. | 23.84 Million USD | -26313.732% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -3738.9% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -959.823% |
| NLS Pharmaceutics AG | 10.68 Million USD | -58864.81% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -387772.625% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -16077.877% |
| Gritstone bio, Inc. | 125.91 Million USD | -4901.28% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -42810.616% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -123657.587% |
| Avid Bioservices, Inc. | 275.66 Million USD | -2184.473% |
| Insmed Incorporated | 1.66 Billion USD | -278.969% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -81750.044% |
| MediWound Ltd. | 27.18 Million USD | -23063.872% |
| OmniAb, Inc. | 87.4 Million USD | -7105.449% |
| Alector, Inc. | 487.66 Million USD | -1191.36% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -1460.904% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -34079.441% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -16311.44% |
| Zai Lab Limited | 240.17 Million USD | -2522.05% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -899.521% |
| Aura Biosciences, Inc. | 29.22 Million USD | -21447.069% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -6523.644% |
| Immunic, Inc. | 25.36 Million USD | -24724.827% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -8995.791% |
| Veracyte, Inc. | 93.71 Million USD | -6619.621% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -240570.577% |
| FibroGen, Inc. | 585.72 Million USD | -975.168% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -36128.281% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -964192.364% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -111253.705% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 17.747% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -76718.273% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -7395.135% |
| TG Therapeutics, Inc. | 169.08 Million USD | -3624.495% |
| Galecto, Inc. | 5.89 Million USD | -106710.753% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -75920.787% |
| Fortrea Holdings Inc. | 2.61 Billion USD | -140.512% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -21749.844% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -49797.488% |
| XBiotech Inc. | 8.39 Million USD | -74897.761% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -42810.616% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -11741.974% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -1634.359% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -23324.944% |
| Theravance Biopharma, Inc. | 169 Million USD | -3626.28% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | -418.062% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -1158.44% |
| Vaxxinity, Inc. | 30.94 Million USD | -20251.48% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | -547.572% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -104318.011% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | -745.045% |
| NexImmune, Inc. | 5.08 Million USD | -123764.568% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -1695555.288% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -204708.888% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 11.391% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -122087.143% |
| Scopus BioPharma Inc. | 7.45 Million USD | -84380.753% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -23850.567% |
| Ainos, Inc. | 7.39 Million USD | -85068.678% |
| Pluri Inc. | 34.11 Million USD | -18361.427% |
| Prothena Corporation plc | 135.01 Million USD | -4564.273% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -2490.491% |
| Celularity Inc. | 102.92 Million USD | -6018.355% |
| Rallybio Corporation | 9.43 Million USD | -66639.741% |
| Cue Biopharma, Inc. | 24.44 Million USD | -25662.168% |
| MeiraGTx Holdings plc | 319.99 Million USD | -1868.043% |
| Omeros Corporation | 403.25 Million USD | -1461.694% |
| Humacyte, Inc. | 114.67 Million USD | -5391.565% |
| Immunocore Holdings plc | 228.15 Million USD | -2660.176% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -129080.759% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -8106.362% |
| Blueprint Medicines Corporation | 918.64 Million USD | -585.53% |
| CalciMedica, Inc. | 4.02 Million USD | -156244.638% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -35985.045% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -3985.532% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -7238.362% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -2166.998% |
| Pulmatrix, Inc. | 15.96 Million USD | -39350.993% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -39826.216% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -25493.603% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -2410.91% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -12300.191% |
| Cytokinetics, Incorporated | 1.21 Billion USD | -420.185% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -19714.247% |
| Nutriband Inc. | 1.07 Million USD | -583591.825% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -59126.578% |
| Vor Biopharma Inc. | 59.1 Million USD | -10555.052% |
| Roivant Sciences Ltd. | 773.95 Million USD | -713.688% |
| Evogene Ltd. | 17.99 Million USD | -34905.903% |
| ProKidney Corp. | 29.21 Million USD | -21455.182% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -8649.166% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -893192.746% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | -233.396% |
| CorMedix Inc. | 11.91 Million USD | -52742.855% |
| BioLineRx Ltd. | 50.7 Million USD | -12320.737% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -4113.572% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -7020.636% |
| Atai Life Sciences N.V. | 49.16 Million USD | -12709.817% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -20115.396% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -34960.472% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -4952.763% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -111282.42% |
| MediciNova, Inc. | 3.89 Million USD | -161726.448% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -34352.443% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -418553.793% |
| GeoVax Labs, Inc. | 3.51 Million USD | -178814.06% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -1485.253% |
| Biomea Fusion, Inc. | 30.69 Million USD | -20419.915% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | -131.38% |
| Mereo BioPharma Group plc | 15.96 Million USD | -39353.464% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -20083.847% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -10631.31% |
| Absci Corporation | 58.3 Million USD | -10701.252% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -32961.539% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -19541.826% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -8434.438% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -7098.612% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -18548.392% |
| Allakos Inc. | 74.79 Million USD | -8319.989% |
| Imunon, Inc. | 8.53 Million USD | -73724.698% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -27887.921% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -5385.108% |
| BioAtla, Inc. | 48.98 Million USD | -12755.84% |
| NLS Pharmaceutics AG | 10.68 Million USD | -58864.81% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -226512.522% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -4721.875% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -44202.23% |
| XOMA Corporation | 145.58 Million USD | -4225.843% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -18606.556% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -9058.891% |
| aTyr Pharma, Inc. | 31.59 Million USD | -19830.886% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -10086.439% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -13905.475% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -12910.954% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -219327.247% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -77094.755% |
| Akari Therapeutics, Plc | 4.58 Million USD | -137281.37% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -35412.975% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | -281.795% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -1559057.531% |
| UroGen Pharma Ltd. | 243.52 Million USD | -2486.023% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -1861.326% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -227943.807% |
| Orgenesis Inc. | 35.53 Million USD | -17622.139% |
| Entera Bio Ltd. | 1.37 Million USD | -456575.997% |
| GH Research PLC | 6.7 Million USD | -93879.436% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -92511.206% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -33351.408% |
| Xencor, Inc. | 283.55 Million USD | -2120.9% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -210825.905% |
| Replimune Group, Inc. | 113.21 Million USD | -5462.529% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -167516.515% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -5982.838% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -1559057.531% |
| Portage Biotech Inc. | 4.45 Million USD | -141418.247% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -418553.793% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -27221.31% |
| OncoCyte Corporation | 49.29 Million USD | -12674.478% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -152132.508% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -789578.79% |
| Purple Biotech Ltd. | 10 Million USD | -62844.148% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -108741.376% |
| scPharmaceuticals Inc. | 57.26 Million USD | -10897.995% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -50735.9% |
| HilleVax, Inc. | 78.9 Million USD | -7880.791% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -124604.198% |
| Tharimmune, Inc. | 1.81 Million USD | -346864.319% |
| Genprex, Inc. | 3.25 Million USD | -193420.574% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -23121.955% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -120174.293% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -3056968.932% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -1756306.952% |
| OKYO Pharma Limited | 7.42 Million USD | -84763.127% |
| Savara Inc. | 37.19 Million USD | -16832.572% |
| Curis, Inc. | 57.61 Million USD | -10830.99% |
| Daré Bioscience, Inc. | 26.32 Million USD | -23817.952% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -15965.294% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -436019.252% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -30149.109% |
| BeiGene, Ltd. | 2.23 Billion USD | -181.929% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -29480.184% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -2300.013% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -29502.153% |
| Erasca, Inc. | 78.61 Million USD | -7911.044% |
| bluebird bio, Inc. | 424.62 Million USD | -1383.091% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -960990.084% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | -233.195% |
| DBV Technologies S.A. | 42.8 Million USD | -14613.93% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -960990.084% |
| Moderna, Inc. | 4.57 Billion USD | -37.742% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -89929.478% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -380187.56% |
| Molecular Templates, Inc. | 31.17 Million USD | -20103.272% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -36792.572% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -970.826% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -4958.08% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -22852.808% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -17174.418% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -11219.425% |
| MacroGenics, Inc. | 154.2 Million USD | -3983.837% |
| RenovoRx, Inc. | 4.46 Million USD | -140911.24% |
| Adicet Bio, Inc. | 37.12 Million USD | -16865.415% |
| Prime Medicine, Inc. | 60.78 Million USD | -10261.241% |
| Aditxt, Inc. | 28.53 Million USD | -21972.268% |
| Adagene Inc. | 45.16 Million USD | -13842.116% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -3484973.132% |
| Quantum-Si incorporated | 26.63 Million USD | -23547.486% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | -802.791% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -206890.644% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -5377.999% |
| SciSparc Ltd. | 1.59 Million USD | -394731.473% |
| Vericel Corporation | 127.7 Million USD | -4831.335% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -113065.893% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -7277.814% |
| Generation Bio Co. | 171.63 Million USD | -3569.266% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -54424.346% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -14954.773% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -2392.13% |
| Invivyd, Inc. | 51.71 Million USD | -12077.909% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -6746.888% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -96707.364% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -8241.584% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -616703.33% |
| 2seventy bio, Inc. | 310.12 Million USD | -1930.646% |
| ADMA Biologics, Inc. | 193.97 Million USD | -3146.568% |
| Clene Inc. | 38.95 Million USD | -16067.908% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -17328.905% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -2350.642% |
| GeoVax Labs, Inc. | 3.51 Million USD | -178814.06% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -3209.925% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -51605.556% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -3075.423% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -51541.372% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -12989.651% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -11817.946% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -1602.716% |
| Evaxion Biotech A/S | 17.61 Million USD | -35646.1% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -3813.255% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -4011.056% |
| Trevena, Inc. | 48.26 Million USD | -12948.697% |
| Surrozen, Inc. | 8.14 Million USD | -77218.134% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -29062.13% |
| Cingulate Inc. | 10.36 Million USD | -60682.203% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -228902.255% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -16787.166% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -175489.764% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -47790.205% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -1885.354% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -25243.322% |
| Clearmind Medicine Inc. | 3.61 Million USD | -174347.314% |
| Kronos Bio, Inc. | 54.2 Million USD | -11518.904% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -13286.821% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -27569.755% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -31276.424% |
| Statera Biopharma, Inc. | 22.67 Million USD | -27671.371% |
| ImmunityBio, Inc. | 1.09 Billion USD | -477.552% |
| Korro Bio, Inc. | 51.75 Million USD | -12068.732% |
| Kineta, Inc. | 7.22 Million USD | -87099.695% |
| BioVie Inc. | 9.7 Million USD | -64809.066% |
| Codexis, Inc. | 49.94 Million USD | -12508.741% |
| Celularity Inc. | 102.92 Million USD | -6018.355% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -6443.126% |
| Celcuity Inc. | 51.45 Million USD | -12140.141% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -1824254.421% |
| Cibus, Inc. | 206.11 Million USD | -2955.334% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -14726.514% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -23809.647% |
| IN8bio, Inc. | 8.77 Million USD | -71691.632% |
| Kodiak Sciences Inc. | 213.59 Million USD | -2848.421% |
| Annexon, Inc. | 47.11 Million USD | -13265.512% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -6933.16% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -6434.639% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -45904.544% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | -141.899% |
| Eyenovia, Inc. | 19.78 Million USD | -31737.578% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -3456.217% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -81888.83% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -26032.047% |
| Arcellx, Inc. | 339.75 Million USD | -1753.576% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -52829.585% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -2464.78% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -65753.414% |
| Moolec Science SA | 13.94 Million USD | -45058.847% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -14493.905% |
| Geron Corporation | 146.12 Million USD | -4209.65% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -12362.523% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -15732.567% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -2138973.932% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -255869.112% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -3229.295% |
| Humacyte, Inc. | 114.67 Million USD | -5391.565% |
| Structure Therapeutics Inc. | 29.05 Million USD | -21577.605% |
| 89bio, Inc. | 59.96 Million USD | -10402.413% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -23697.612% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -526452.007% |
| Genelux Corporation | 8.42 Million USD | -74692.898% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -91754.755% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -4519.724% |
| Notable Labs, Ltd. | 4.42 Million USD | -142153.49% |
| Liquidia Corporation | 73.13 Million USD | -8510.52% |
| Mustang Bio, Inc. | 17.61 Million USD | -35643.016% |
| Immunovant, Inc. | 48.95 Million USD | -12763.981% |
| Quantum-Si incorporated | 26.63 Million USD | -23547.486% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -16307.165% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -202850.757% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -8426.234% |
| Acasti Pharma Inc. | 11.55 Million USD | -54391.321% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -27755.791% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -231563.776% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -16977.208% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -461990.396% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -103206.463% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -25257.608% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -27063.397% |
| PepGen Inc. | 34.63 Million USD | -18084.754% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -51757.395% |
| United Therapeutics Corporation | 1.18 Billion USD | -432.699% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -90071.277% |
| Solid Biosciences Inc. | 38.45 Million USD | -16275.168% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -73493.782% |
| Immuneering Corporation | 12 Million USD | -52343.17% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -2006400.392% |
| Silo Pharma, Inc. | 1.56 Million USD | -401205.193% |
| Belite Bio, Inc | 4.21 Million USD | -149450.273% |
| XOMA Corporation | 145.58 Million USD | -4225.843% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -259272.405% |
| Bionomics Limited | 10.15 Million USD | -61891.682% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -29203.253% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -27384.668% |
| uniQure N.V. | 624.01 Million USD | -909.194% |
| Cassava Sciences, Inc. | 14.19 Million USD | -44264.65% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -3484973.132% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -3600.443% |
| Forte Biosciences, Inc. | 3.66 Million USD | -171682.924% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -2416620.2% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -93238.699% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -81888.83% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -36128.281% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -59490.859% |
| Altimmune, Inc. | 16.54 Million USD | -37972.438% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -919.508% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -27384.668% |
| Compugen Ltd. | 55.77 Million USD | -11191.012% |
| Peak Bio, Inc. | 20.75 Million USD | -30244.777% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -5601.06% |
| Benitec Biopharma Inc. | 4.96 Million USD | -126815.8% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -3889.763% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -8277.314% |
| Zura Bio Limited | 21.29 Million USD | -29477.128% |
| PolyPid Ltd. | 17.46 Million USD | -35951.992% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -5502.863% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -8277.314% |
| Instil Bio, Inc. | 99.8 Million USD | -6210.119% |
| argenx SE | 444.95 Million USD | -1315.338% |
| Immunome, Inc. | 28.65 Million USD | -21874.883% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -75437.507% |
| Verona Pharma plc | 58.84 Million USD | -10602.677% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -43412.485% |
| Shattuck Labs, Inc. | 14.85 Million USD | -42282.139% |
| CervoMed Inc. | 2.59 Million USD | -242510.778% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -129107.263% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -49346.938% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -59677.523% |
| Moolec Science SA | 13.94 Million USD | -45058.847% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -268624.184% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -11227.509% |
| AnaptysBio, Inc. | 364.28 Million USD | -1628.741% |
| Design Therapeutics, Inc. | 11.95 Million USD | -52572.817% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -49549.653% |
| NeurAxis, Inc. | 1.91 Million USD | -329143.143% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -16077.461% |
| Lumos Pharma, Inc. | 13.33 Million USD | -47132.896% |
| Achilles Therapeutics plc | 19.08 Million USD | -32893.985% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -43412.485% |
| 180 Life Sciences Corp. | 5.38 Million USD | -116798.416% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -26598.171% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -27569.755% |
| Nutriband Inc. | 1.07 Million USD | -583591.825% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -20481.613% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -43298.539% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -1469.392% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -19293.225% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -48160.523% |
| Palisade Bio, Inc. | 2.73 Million USD | -229821.942% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -119785.056% |
| Beam Therapeutics Inc. | 478.38 Million USD | -1216.421% |
| Neurogene Inc. | 36.54 Million USD | -17130.463% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -1482.497% |
| AEON Biopharma, Inc. | 159.88 Million USD | -3838.709% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -13116.29% |
| Sesen Bio, Inc. | 30.98 Million USD | -20225.207% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -24157.779% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -82738.504% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -3117.343% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -3179.007% |
| Athira Pharma, Inc. | 30.05 Million USD | -20852.064% |
| Vaccinex, Inc. | 5.94 Million USD | -105883.877% |
| HCW Biologics Inc. | 15.05 Million USD | -41738.864% |
| XOMA Corporation | 145.58 Million USD | -4225.843% |
| Nektar Therapeutics | 267.04 Million USD | -2258.231% |
| Arvinas, Inc. | 644.6 Million USD | -876.972% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -35412.975% |
| Merus N.V. | 102.15 Million USD | -6064.954% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -4203.083% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -6520.65% |
| Rezolute, Inc. | 11.73 Million USD | -53569.354% |
| Clene Inc. | 38.95 Million USD | -16067.908% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -221070.409% |
| BeyondSpring Inc. | 48.26 Million USD | -12946.804% |
| Synlogic, Inc. | 32.89 Million USD | -19044.435% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -42995.613% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -385307.711% |
| Peak Bio, Inc. | 20.75 Million USD | -30244.777% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -9823.828% |
| Krystal Biotech, Inc. | 39.71 Million USD | -15757.285% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -1572.02% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -6224.822% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -1455223.23% |
| MannKind Corporation | 721.36 Million USD | -773.005% |
| Ikena Oncology, Inc. | 22.33 Million USD | -28095.935% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -301796.548% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -6038.573% |
| Gossamer Bio, Inc. | 249.14 Million USD | -2427.649% |
| CohBar, Inc. | 1.03 Million USD | -609161.85% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -58816.288% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -32961.539% |
| Legend Biotech Corporation | 589.93 Million USD | -967.505% |
| Mural Oncology plc | 37.92 Million USD | -16503.992% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -4648.004% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -274263.883% |
| Disc Medicine, Inc. | 22.87 Million USD | -27430.326% |
| Champions Oncology, Inc. | 28.03 Million USD | -22363.214% |
| REGENXBIO Inc. | 262.22 Million USD | -2301.56% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -187363.594% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -50143.833% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -46786.07% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -29598.477% |
| Vaxart, Inc. | 34.02 Million USD | -18408.632% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -30786.657% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -21972.018% |
| Cellectis S.A. | 249.57 Million USD | -2423.314% |
| Longeveron Inc. | 5.33 Million USD | -117898.164% |
| Repare Therapeutics Inc. | 41.81 Million USD | -14959.093% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | -161.827% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -10331.954% |
| Revolution Medicines, Inc. | 262.39 Million USD | -2300.013% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -298787.613% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -72906.747% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -53264.647% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -44744.848% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -292673.687% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | -22.288% |
| Denali Therapeutics Inc. | 122.96 Million USD | -5021.51% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -113065.893% |
| Veru Inc. | 32.81 Million USD | -19092.449% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -91580.914% |
| Cingulate Inc. | 10.36 Million USD | -60682.203% |
| Passage Bio, Inc. | 39.26 Million USD | -15939.84% |
| Context Therapeutics Inc. | 4.19 Million USD | -150138.315% |
| Exicure, Inc. | 8.54 Million USD | -73564.312% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -21241.88% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -59956.857% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -28472.034% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -3763.867% |
| Nuvalent, Inc. | 31.82 Million USD | -19689.341% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -98892.946% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -9892.641% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -34886.456% |
| OmniAb, Inc. | 87.4 Million USD | -7105.449% |
| Anew Medical, Inc. | 8.24 Million USD | -76310.041% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -16347.404% |
| Lipocine Inc. | 2.63 Million USD | -239202.804% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -23870.623% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -15560.902% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -23537.889% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -7209.657% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -116499.926% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -7510.623% |
| Ocugen, Inc. | 23.98 Million USD | -26158.441% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -13470.285% |
| Q32 Bio Inc. | 233.12 Million USD | -2601.332% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -69363.512% |
| Alumis Inc. Common Stock | 53.5 Million USD | -11670.704% |
| Equillium, Inc. | 27.95 Million USD | -22425.886% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -2948.309% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -111823.528% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -102583.758% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -3902.874% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -8969.984% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -63038.511% |
| Dominari Holdings Inc. | 4.63 Million USD | -135769.73% |
| Edesa Biotech, Inc. | 1.84 Million USD | -341854.576% |
| vTv Therapeutics Inc. | 29.56 Million USD | -21199.293% |
| Bio-Techne Corporation | 744.34 Million USD | -746.06% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -4894.141% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -1728.263% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -15420.794% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -21647.978% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -6718.495% |
| Nkarta, Inc. | 105.6 Million USD | -5863.6% |
| BioCardia, Inc. | 4.59 Million USD | -137101.786% |
| Iterum Therapeutics plc | 32.66 Million USD | -19181.005% |